drug protocol number

MS700568-2

drug sponsor

King Fahad Medical City

drug study

Cladribine

drug trial site

King Fahad Medical City (Riyadh),King Saud Medical City (Riyadh),King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah),King Faisal Specialist Hospital and Research Center (Jeddah),Dallah Hospital (Riyadh),King Fahd Armed Forces Hospital (Jeddah),King Fahd Military Medical Complex (Dhahran), Prince Sultan Military Medical City (Riyadh)

drug status

Ongoing

drug phase